| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.18B | $ 2.88B | $ 2.33B | $ 1.94B | $ 1.69B |
| Gross Profit | $ 2.80B | $ 2.57B | $ 2.07B | $ 1.79B | $ 1.56B |
| Operating Income | $ 1.52B | $ 1.38B | $ 1.18B | $ 979.70M | $ 555.90M |
| EBITDA | $ 1.82B | $ 1.65B | $ 1.39B | $ 1.04B | $ 736.80M |
| Net Income | $ 1.33B | $ 1.20B | $ 984.80M | $ 727.30M | $ 475.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.56B | $ 3.27B | $ 2.99B | $ 2.84B | $ 1.93B |
| Total Assets | $ 7.88B | $ 7.36B | $ 7.17B | $ 6.04B | $ 5.17B |
| Total Debt | $ 37.60M | $ 300.00M | $ 700.00M | $ 800.00M | $ 800.00M |
| Net Debt | $ -1.52B | $ -1.40B | $ -507.70M | $ -161.20M | $ -94.80M |
| Total Liabilities | $ 783.80M | $ 920.00M | $ 1.18B | $ 1.25B | $ 1.21B |
| Stockholders' Equity | $ 7.10B | $ 6.44B | $ 5.98B | $ 4.80B | $ 3.96B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.04B | $ 1.08B | $ 747.60M | $ 663.70M | $ 477.40M |
| Operating Cash Flow | $ 1.56B | $ 1.33B | $ 978.00M | $ 802.50M | $ 598.20M |
| Investing Cash Flow | $ -551.30M | $ 417.20M | $ -719.60M | $ -811.50M | $ -486.90M |
| Financing Cash Flow | $ -1.15B | $ -1.25B | $ -11.90M | $ 75.40M | $ 44.80M |
United Therapeutics (CH:UTH)
:UTH
